These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32472930)

  • 61. Myocardial Native T1 Time in Patients With Hypertrophic Cardiomyopathy.
    Kato S; Nakamori S; Bellm S; Jang J; Basha T; Maron M; Manning WJ; Nezafat R
    Am J Cardiol; 2016 Oct; 118(7):1057-62. PubMed ID: 27567135
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
    J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Left Ventricular Myocardial Fibrosis, Atrophy, and Impaired Contractility in Patients With Pulmonary Arterial Hypertension and a Preserved Left Ventricular Function: A Cardiac Magnetic Resonance Study.
    Homsi R; Luetkens JA; Skowasch D; Pizarro C; Sprinkart AM; Gieseke J; Meyer Zur Heide Gen Meyer-Arend J; Schild HH; Naehle CP
    J Thorac Imaging; 2017 Jan; 32(1):36-42. PubMed ID: 27861208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Late gadolinium enhancement CMR in primary mitral regurgitation.
    Van De Heyning CM; Magne J; Piérard LA; Bruyère PJ; Davin L; De Maeyer C; Paelinck BP; Vrints CJ; Lancellotti P
    Eur J Clin Invest; 2014 Sep; 44(9):840-7. PubMed ID: 25066426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study.
    Yi JE; Park J; Lee HJ; Shin DG; Kim Y; Kim M; Kwon K; Pyun WB; Kim YJ; Joung B
    PLoS One; 2018; 13(11):e0208100. PubMed ID: 30485353
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes.
    Price AM; Hayer MK; Vijapurapu R; Fyyaz SA; Moody WE; Ferro CJ; Townend JN; Steeds RP; Edwards NC
    BMC Cardiovasc Disord; 2019 Dec; 19(1):295. PubMed ID: 31842769
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myocardial fibrosis in patients with a history of Kawasaki disease.
    Dusenbery SM; Newburger JW; Colan SD; Gauvreau K; Baker A; Powell AJ
    Int J Cardiol Heart Vasc; 2021 Feb; 32():100713. PubMed ID: 33521237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes.
    Andresen K; Klæboe LG; Lie ØH; Broch K; Kvaslerud AB; Bosse G; Hopp E; de Lange C; Haugaa KH; Edvardsen T
    Sci Rep; 2024 Mar; 14(1):6581. PubMed ID: 38503845
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of morphological and functional adaptations of the heart in highly trained triathletes and long-distance runners using cardiac magnetic resonance imaging.
    Franzen E; Mangold S; Erz G; Claussen CD; Niess AM; Kramer U; Burgstahler C
    Heart Vessels; 2013 Sep; 28(5):626-31. PubMed ID: 22983606
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Left Ventricular Fibrosis and CMR Tissue Characterization of Papillary Muscles in Mitral Valve Prolapse Patients.
    Spampinato RA; Marin-Cuartas M; Kampen A; Fahr F; Sieg F; Strotdrees E; Jahnke C; Klaeske K; Wiesner K; Morningstar JE; Nagata Y; Izquierdo-Garcia D; Dieterlen MT; Norris RA; Levine RA; Paetsch I; Borger MA
    Res Sq; 2023 May; ():. PubMed ID: 37292932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sex differences in myocardial remodeling and extracellular volume in aortic regurgitation.
    Malahfji M; Senapati A; Debs D; Saeed M; Tayal B; Nguyen DT; Graviss EA; Shah DJ
    Sci Rep; 2023 Jul; 13(1):11334. PubMed ID: 37443191
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.
    Tham EB; Haykowsky MJ; Chow K; Spavor M; Kaneko S; Khoo NS; Pagano JJ; Mackie AS; Thompson RB
    J Cardiovasc Magn Reson; 2013 Jun; 15(1):48. PubMed ID: 23758789
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Myocardial Fibrosis in Young and Veteran Athletes: Insights From a Meta-Analysis.
    Androulakis E; Mouselimis D; Tsarouchas A; Antonopoulos A; Bakogiannis C; Papagkikas P; Vlachopoulos C
    Front Cardiovasc Med; 2021; 8():784474. PubMed ID: 34993239
    [No Abstract]   [Full Text] [Related]  

  • 80. Right ventricular fibrosis in adults with uncorrected secundum atrial septal defect and pulmonary hypertension: a cardiovascular magnetic resonance study with late gadolinium enhancement, native T1 and extracellular volume.
    Ginting Munte FA; Elen E; Lelya O; Rudiktyo E; Prakoso R; Lilyasari O
    Front Cardiovasc Med; 2024; 11():1395382. PubMed ID: 38873272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.